Navigation Links
Keith Denner Extends Current Technology's Chairman and CEO Options

VANCOUVER, British Columbia, April 10 /PRNewswire-FirstCall/ -- On July 6, 2006, Current Technology Corporation (the "Company") announced that Keith Denner had granted to the Chairman and to the Chief Executive Officer, for nominal consideration, options ("Options") to purchase common shares in the capital of the Company, from his personal holdings, under the following terms and conditions:

i) total number of shares under option -- 3,000,000;

ii) exercise price -- $0.38 (all funds USD) per share;

iii) vesting -- fifty percent of the options to vest if the Company's

shares close at $0.78 or higher, and the remaining fifty percent to

vest if they close at $1.14 or higher;

iv) term -- the option to expire on July 5, 2008;

v) Mr. Denner to have the right to donate all or a portion of the

3,000,000 shares to a charity or charities, subject to the terms of

the option agreements; and

vi) Robert Kramer must be an officer of the Company at the time of

exercise of the option.

The Company's Board of Directors has reviewed the terms of the options and confirmed they are fair to the Company and that no consideration was provided by the Company to Mr. Denner to induce him to grant the options.

"I have been and remain a long-term supporter of the Company," stated Mr. Denner. "I believe it is in the shareholders' best interests to incentivize the Chairman and CEO of the Company and I am pleased to do my part by offering a portion of my personal holdings to that end. I am very supportive of the Company's recent acquisition of a controlling interest in Celevoke, Inc. and feel it appropriate to extend the term of my option to Mr. Kramer for another year to July 5, 2009."

Mr. Denner owns 16,619,266 common shares (representing approximately 12.83% of the issued and outstanding shares of the Company) and warrants to purchase an additional 27,548,933 common shares. In addition, Mr. Denner holds a convertible promissory note in the principal amount of $1,166,156 issued by the Company. In the aggregate, after giving effect to the exercise of Mr. Denner's warrants and the conversion of the convertible promissory note (and prior to the exercise or conversion of any options, warrants or other convertible securities of the Company by any other holder thereof), Mr. Denner would beneficially own 33.09% of the outstanding shares of the Company. This percentage will be reduced proportionately if other holders exercised their existing options and warrants previously issued by the Company.

Prior to the grant of the Options, Robert Kramer directly held 1,854,337 common shares in the capital of the Company, warrants to purchase an additional 4,250,000 common shares and 7,000,000 options previously granted by the Company. Indirectly through companies 100% controlled by Mr. Kramer, he holds an additional 2,392,666 common shares in the capital of the Company. In the aggregate, after giving effect to the exercise of all previously issued options and warrants held by Mr. Kramer, but prior to the exercise of the Options, he would beneficially own or control 15,497,003 common shares in the capital of the Company, representing 11.01% of the issued and outstanding common shares in the capital of the Company. After giving effect to the exercise of the Options, Mr. Kramer would beneficially own or control 18,497,003 common shares in the capital of the Company, representing 12.87% of the issued and outstanding common shares in the capital of the Company. All of the foregoing numbers are effective as of April 10, 2008.

The Options were acquired in a private transaction for investment purposes only and Mr. Kramer does not have any present intention to further increase his beneficial ownership of, or control or direction over, additional common shares in the capital of the Company. Mr. Kramer may in the future take such actions in respect of his holdings that he deems appropriate in light of the circumstances then existing, including the purchase of additional common shares or other securities of the Company through open market purchases or privately negotiated transactions, or the sale of all or a portion of his holdings in the open market or in privately negotiated transactions.

SOURCE Current Technology Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
2. Therap Services Welcomes Anna Keith to the US Customer Support Team
3. Viant Appoints Keith Vangeison as Executive Vice President of Network Development
4. Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
5. Keith Taft Named General Manager of UltraTape Industries
6. Parker Extends Precise Medical Seal Capability; Acquires Hi-Tech Group Companies
7. The Quantum Group Extends CEOs Employment Agreement
8. Hands on Disaster Response Extends Cyclone Relief Project
9. PROGNOSIS Extends its Popular IP Telephony Management Software to Support Nortel Environments
10. FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
11. Actavis Extends Portfolio With Four New Products in the U.S.
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... certified facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the ... Spa at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized ...
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... music, friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled for March ... , For 65 years, Brillianteen has been a treasured tradition for numerous ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... “While riding ... an inventor, from Bronx, N.Y. “I thought there had to be a convenient and ... the PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: AGN ... the New York State Attorney General,s ... Sherman Act, and other statutes with the Attorney General over ... to cease marketing and selling the now generic version of ... admits no liability, has released its counterclaims against ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Trovagene, Inc. ... diagnostics, today announced that Chief Executive Officer Antonius Schuh, ... the 27 th Annual Piper Jaffray Healthcare Conference. ... at the New York Palace Hotel in ... at 1:30 p.m. EST. Mr. Schuh will be available ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Today AVACEN Medical announced the issue of ... of Thermal Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry ... AVACEN Treatment Method. Photo - ... ... ...
Breaking Medicine Technology: